Jonathan E. Lim

Jonathan E. Lim is a declared insider at 4 companies (board member); the most frequent names are Erasca, Inc., Boundless Bio, Inc. and Ignyta, Inc. The record holds 10 filings, for trades running from 7 January 2016 to 3 February 2025.

No open-market sale appears; the market trades are 6 purchases worth €4.0M. Buying on the open market means paying the going price with one's own funds, a different act from receiving shares as pay. Outside the open market, there are 1 share grant.

Half of the purchases are above €259k and half below. 3 out of 6 purchases came within 30 days of a purchase by at least one other insider of the same company. When several insiders buy within a few weeks of each other, analysts speak of a cluster purchase.

The record was last updated on 4 February 2025 with a transaction in Maze Therapeutics, Inc. The most recent open-market purchase was published on 6 December 2023, 1,047 days ago. Typically, a trade is published a median of 2 days after it takes place. Section 16 rules allow two business days to file each Form 4. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.